filler

2 stories · following the connections

Business

IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors

By Nasdaq OMXNov 10, 2017, 1:00 PM UTC

Business

Topokine Initiates Phase 2 Trial of TAT4 Gel for Topical Reduction of Laugh Lines

By Nasdaq OMXJan 27, 2016, 1:30 PM UTC